GEHC vs. MDLN: GE HealthCare vs. Medline Stock Comparison

Company Profile

GE HealthCare (GEHC) and Medline (MDLN) both belong to the Health Care Equipment & Supplies industry, though GEHC is classified under Health Care Equipment while MDLN falls under Health Care Supplies.

GE HealthCare (GEHC) has traded publicly since December 15, 2022, giving it several years of listed trading history, while Medline (MDLN) only listed on December 17, 2025 and has a limited public-market record.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Medline (MDLN) reports a negative beta of -0.93, suggesting inverse market sensitivity over the measurement window. That is uncommon for ordinary equities and can reflect commodity-linked or hedge-like exposure, but it can also come from statistical noise. GE HealthCare (GEHC) has a non-negative beta of 0.69.

Risk-Adjusted Performance

Risk-Return Positioning

Both GEHC and MDLN need 1-year volatility and 1-year return to plot risk-return positioning.

Risk-Adjusted Metrics

Profitability

GE HealthCare (GEHC) at 20.01% sits in the top ROE quartile, while Medline (MDLN) at 4.85% is closer to the peer norm — stronger capital efficiency for GEHC.

GE HealthCare (GEHC) at 9.95% retains a top-quartile share of revenue as profit, ahead of Medline (MDLN) at 1.85%, which keeps about the industry-typical share.

GE HealthCare (GEHC) at 15.33% operates in the top operating margin quartile, ahead of Medline (MDLN) at 5.22%, which runs around its industry’s norm.

Profitability Metrics

Growth

Only one side can be read here: GE HealthCare (GEHC) reports revenue growth of 4.84%, ranked against its industry; Medline (MDLN) has no revenue growth figure this period.

Medline (MDLN) at 117.38% clears its industry range for EPS growth, a much stronger earnings trajectory than GE HealthCare (GEHC) at 4.84%, which is closer to a typical peer reading.

Growth Metrics

Financial Strength

Medline (MDLN) at 4.04 carries current ratio above its industry’s typical mid-range, while GE HealthCare (GEHC) at 1.30 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.

Both GE HealthCare (GEHC) at 0.88 and Medline (MDLN) at 0.65 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Medline (MDLN) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile GE HealthCare (GEHC) reports a yield of 0.17%, ranking against industry peers normally.

Medline (MDLN) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile GE HealthCare (GEHC) reports a payout of 2.96%, ranking against industry peers normally.

Dividend Metrics

Valuation

GE HealthCare (GEHC) at 17.42 sits in the cheaper P/E ratio quartile, while Medline (MDLN) at 90.09 trades above its peer range — a wide earnings-valuation gap relative to industry peers.

On P/S ratio, both GE HealthCare (GEHC) at 1.72 and Medline (MDLN) at 1.70 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

On P/B ratio, both GE HealthCare (GEHC) at 3.21 and Medline (MDLN) at 2.95 are valued close to their industries’ norm against book — neither stands out from peers.

Valuation Metrics